Search Press releases Keywords From To 25 Jun 2021 UCB Receives Positive CHMP Opinion Recommending Approval of BIMZELX[®*] (bimekizumab) in the EU for the Treatment of Adults with Moderate to Severe Plaque Psoriasis Read More 18 Jun 2021 Disposals of own shares Read More 11 Jun 2021 Disposals of own shares Read More 4 Jun 2021 Disposals of own shares Read More 1 Jun 2021 EULAR 2021: New Data from UCB’s Rheumatology Portfolio Demonstrates Real World Value for Patients with axSpA, PsA, and Women of Childbearing Age Read More 25 May 2021 Disposals of own shares Read More Pagination First page Previous page Previous … Page 53 Page 54 Page 55 Page 56 Current page 57 Page 58 Page 59 Page 60 Page 61 … Page 57 of 63 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
